494 related articles for article (PubMed ID: 21633527)
1. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
2. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
[TBL] [Abstract][Full Text] [Related]
3. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
4. Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution.
Díaz-Jiménez D; De la Fuente M; Dubois-Camacho K; Landskron G; Fuentes J; Pérez T; González MJ; Simian D; Hermoso MA; Quera R
BMC Gastroenterol; 2016 Aug; 16(1):103. PubMed ID: 27565556
[TBL] [Abstract][Full Text] [Related]
5. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Pastorelli L; Garg RR; Hoang SB; Spina L; Mattioli B; Scarpa M; Fiocchi C; Vecchi M; Pizarro TT
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):8017-22. PubMed ID: 20385815
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
[TBL] [Abstract][Full Text] [Related]
9. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
11. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
12. Red cell distribution width for assessment of activity of inflammatory bowel disease.
Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
[TBL] [Abstract][Full Text] [Related]
13. Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis.
Floer M; Clausen M; Meister T; Vollenberg R; Bettenworth D; Tepasse PR
Adv Clin Exp Med; 2021 Jul; 30(7):655-660. PubMed ID: 34286513
[TBL] [Abstract][Full Text] [Related]
14. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.
Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187
[TBL] [Abstract][Full Text] [Related]
15. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
Kucharzik T; Stoll R; Lügering N; Domschke W
Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
17. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?
Oztas E; Kuzu UB; Zengin NI; Kalkan IH; Saygili F; Yildiz H; Celik HT; Akdogan M; Kilic MY; Koksal AS; Odemis B; Suna N; Kayacetin E
Medicine (Baltimore); 2015 Nov; 94(47):e1889. PubMed ID: 26632683
[TBL] [Abstract][Full Text] [Related]
18. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
[TBL] [Abstract][Full Text] [Related]
19. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.
Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME
Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012
[TBL] [Abstract][Full Text] [Related]
20. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]